Latest Period
Q2 2026
CUSIP: 62856X300
Latest Period
Q2 2026
Institutions Reporting
21
Shares (Excl. Options)
736,752
Price
$3.90
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 21 institutions filings for Q2 2026.
Security key
62856X300
Latest holder period
Q2 2026
13F holders
21
13D/G owners
1
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP 62856X300:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| PharmaCyte Biotech, Inc. | 74% | $28,646,744 | 8,475,368 | PharmaCyte Biotech, Inc. | 14 Nov 2025 |
As of 30 Jun 2026, 21 institutional investors reported holding 736,752 shares of Q/C TECHNOLOGIES, INC. - Common Stock, par value $0.001 per share (QCLS). This represents 6.4% of the company’s total 11,453,200 outstanding shares.
Quarter history
Holder count, reported shares/value, and median price by quarter.